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1. Introduction 
 The UV- VIS spectrophotometric assay of drugs rarely involves the measurement of absorbance of samples 
containing only one absorbing component. The pharmaceutical analyst frequently encounters the situation where the 
concentration of one or more substances is required in samples known to contain other absorbing substances, which 
potentially interfere in the assay. If the formula of the samples is known, the identity and concentration of the interfering  
substance are known and the extent of interference in the assay may be determined. The U.V. Spectrophotometric 
techniques for multicomponent samples is the property that at all wavelengths the absorbance of a solution is the sum of 
absorbance of the individual components or  The measured absorbance is the difference between the total absorbance of the 
solution in the sample cell and that of the solution in the reference cell.  In absorbance ratio method (ARM) absorbances are 
measured at two wavelengths, one is being wavelength (λ1) of equal absorptivity of two components i.e. an isoabsorptive 
point and other being λ max of one of the component16. From the literature review7-13 it has been found that only three 
analytical methods for the above combination have been reported. Therefore the attempt is made to develop simple, 
accurate, precise rapid and economical UV-VIS spectrophotometric method for determination of Atenolol (ATN) and 
Chlorthalidone (CTN) in combine dosage form. Atenolol [Figure 1] Chemically is RS)-2-{4-[2-Hydroxy-3-(propan-2 
ylamino)propoxy]phenyl}acetamide. It is white to almost white powder used as anti- hypertensive having solubility in methanol and 
water, sparingly soluble in ethanol. While chlorthalidone [Figure 2] chemically is (RS)-2-chloro-5-(3-Hydroxy-1-
oxoisoindolin-3-yl) benzenesulphonamide.5, 6, 14, 15 It is white to yellowish white crystalline and practically odorless. Used as 
anti-hypertensive having solubility in methanol and insoluble in water, slightly soluble in ethanol.  
                             
Figure 1 Chemical Structure of Atenolol             Figure 2 Chemical Structure of Chlorthalidone 
Abstract 
 A simple, precise, reproducible, accurate, economical & rapid UV-VIS 
Spectrophotometric method have been developed and validated for the simultaneous 
estimation of ATN and CTN in tablet dosage form. This paper describes the absorption 
ratio method as a quantification parameter. The absorption ratio method (ARM) 
involves measurement of absorbance of sample solution is measured at 240.0 nm 
(Isobestic Point) and 251.0 nm (ƛ  max of CTN) and based on E 1% 1cm values at these 
wavelengths two set of equations were framed. The developed method obeys the beers 
law in the concentration range of 40-80µg/mL for ATN and 10-50 µg/mL for CTN. The 
recovery studies shows %RSD for ATN 0.21 and for CTN 1.34 by ARM method. The 
results of analysis have been validated statistically for accuracy, precision, repeatability, 
specificity and ruggedness. The method was successfully applied to the determination 
of these drugs in pharmaceutical dosage form. 
 
  
International Journal of Advances in Pharmaceutics 
ISSN: 2320–4923; DOI: 10.7439/ijap 
Volume 3 Issue 1 [2014] 
Journal home page:http://ijap.ssjournals.com  
International Journal of Advances in Pharmaceutics 3 (1) 2014                                                                                   20 
 
 
2. Experimental 
2.1 Reagents & Chemicals 
Standard samples of ATN & CTN were received as gift samples from the leben laboratories akola (Maharashtra) 
and IPCA Laboratories mumbai (Maharashtra). The marketed formulation Tenoric (IPCA Laboratories) was purchased from 
the local market containing ATN 50 mg and CTN 12.5 mg and all the chemicals used were are of analytical grade.  
2.2 Instruments 
A Shimadzu UV- VIS double beam spectrophotometer with model UV 1700 and software UV probe 2.33was used 
for spectral and absorbance measurement. Analytical balance of citizen model CY 104 (microanalytical balance) was used 
for weighing purpose also the ultrasonicator servewell instruments model RC-SYSTEM MU-1700 used for sonication 
purpose.  
2.3 Selection of Common Solvent 
Methanol was selected as common solvent after assessing the solubilities of both the drugs in different solvents. 
2.4 Preparation of Standard Stock Solutions 
Standard Stock Solution (A) Accurately weighed  quantity of ATN (10.0 mg) was transferred to 10.0 mL volumetric flask 
and dissolved in methanol. The volume was made up to mark with methanol to get final concentration of (1000 µg/mL of 
ATN). The resultant solution was then sonicated for 10.0 min in ultrasonicator.  
Standard Stock Solution (B) Accurately weighed quantity of CTN (10.0 mg) was transferred to 10.0 mL volumetric flask and 
dissolved in methanol. The volume was made up to mark with methanol to get final concentration of (1000 µg/mL of CTN). 
The resultant solution was then sonicated for 10.0 min in ultrasonicator. 
2.5 Study of Overlain Spectra and Determination of   max of ATN & CTN 
Aliquot portions of 0.1 mL of standard stock solutions of ATN (A) and CTN (B) were transferred to the two 
separate 10.0 mL volumetric flask and then the volume was made up to the mark with methanol to get final concentration of 
(10.0 µg/mL of ATN & CTN) respectively. Both the solutions were scanned separately in the range of 400-200 nm against 
methanol as blank. The resulting overlain spectrum is shown in Figure 3. 
2.6 Linearity Study 
ATN aliquot portions of 0.4 to 0.8 mL of standard stock solution of ATN (A) were transferred to five 10.0 mL 
volumetric flasks and then the volume was made up to the mark with methanol to get final concentrations in the range of 
(40 to 80 µg/mL of ATN) respectively. The absorbances of these solutions were measured at 227.0 nm (  max of ATN) then 
the calibration curve (absorbance vs concentration) was plotted shown in Figure 4 absorbances are shown in Table 1. 
CTN aliquot portion of 0.1, 0.12, 0.15, 0.17,0.2 mL of standard stock solution of CTN (B) were transferred to five 
10.0 mL volumetric flasks and then the volume was made up to the mark with methanol to get final concentrations of (10.0, 
12.5, 15.0, 17.5, 20.0 µg/mL of CTN) respectively. The absorbances of these solutions were measured at 251.0 nm (  max of 
CTN) then the calibration curve (absorbance vs concentration) was plotted shown in Figure 5 absorbances shown in Table 
2. 
2.7 Determinations of E (1% 1cm) Values at Selected Wavelengths  
Aliquot portions of 0.4 mL of standard stock solutions of ATN (A) were transferred to five separate 10.0 mL 
volumetric flask and then the volume was made up to the mark with methanol, to get 5 dilutions having concentrations of 
(40.0 µg/mL of ATN) respectively. similarly aliquot portions of 0.1 mL of standard stock solutions of CTN (B) were 
transferred to five separate 10.0 mL volumetric flask and then volume was made up to the mark with methanol, to get 5 
dilutions having concentration of (10.0 µg/mL of CTN) respectively. Then the absorbances of these solutions were 
measured at the wavelengths of 227.0 nm, 251.0 nm and 240.0 nm.  
E (1%1cm) values of drugs were calculated using following formula: 
                   E (1%1cm) =   Absorbance / Concentration (g / 100 mL) 
The results of E (1%1cm) values of both the drugs shown at selected wavelengths shown in Table 3. 
Absorption Ratio Method (ARM) In this method absorbance of sample solution is measured at 240.0 nm (Isobestic Point) 
and 251.0 nm (  max of CTN) and based on E (1% 1cm) values at selected wavelengths a set of two equations are framed 
which are given below. 
                                                Qm – Qy                   A 
                                CATN   =   ------------      X       ------   …………………….(1) 
                                                 Qx – Qy                  ax 
                                                 Qm – Qx                  A 
                                CCTN    =  ------------       X       ------  ……………………..(2) 
                                                 Qy – Qx                  ay 
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Where, 
                                           Absorbance of sample at 251.0 nm 
                         Qm = 
                                           Absorbance of sample at 240.0 nm 
 
 
                                           Absorptivity of ATN at 251.0 nm 
                         Qx = 
                                           Absorptivity of ATN at 240.0 nm 
 
                                            Absorptivity of CTN at 251.0 nm 
                          Qy = 
                                            Absorptivity of CTN at 240.0 nm 
A is the absorbance of mixture at 240.0 nm and ax, ax2 and ay, ay2 are E (1%, 1 cm) of ATN and CTN at 240.0 nm 
and 251.0 nm and Qm= A2/A, Qy = ay2/ay and Qx = ax2/ax. 
2.8 Analysis of the Standard Laboratory Mixtures 
Standard laboratory mixtures were prepared by accurately weighed 50.0 mg of ATN and 12.5 mg of CTN (as per 
labeled requirement of marketed formulation) was transferred to 50.0 mL volumetric flask and dissolved in sufficient 
quantity of methanol. Then the volume was made up to the mark with methanol. The resultant solution was then sonicated 
in ultrasonicator for 10.0 min. Aliquot portion of 0.4 mL was then transferred to six separate 10.0 mL volumetric flask and 
then volume was made up to the mark with methanol to get final concentrations of (40.0 µg/mL of ATN and 10.0 µg/mL of 
CTN) respectively. Then the absorbances of resultant solutions were measured at 251.0 nm, 240.0 nm. Then these measured 
absorbances put in equation (1) & (2) for (ARM). 
2.9 Analysis of the Marketed Formulation by Proposed Method 
Ten tablets were weighed accurately and ground to fine powder. An accurately weighed quantity of Tablet powder 
equivalent to (50 mg of ATN & 12.5 mg of CTN) were transferred to 50.0 mL of volumetric flask and dissolved in sufficient 
amount of methanol. Then the volume was made up to the mark with methanol. The resultant solution was then filtered 
through whatman filter paper (no. 41). The filtered solution was then sonicated in ultrasonicator for 10.0 min. aliquot 
portion of 0.4 mL was then transferred to the six separate 10.0 mL volumetric flask and then the volume was mad up to the 
mark with methanol to get final concentrations of (40.0 µg/mL of ATN and 10.0 µg/mL of CTN) respectively. Then the 
absorbances of resultant solutions were measured at 251.0 nm, 240.0. Then these measured absorbances put in equation (1) 
& (2) for (ARM).  
2.10 Method Validation 
1. Accuracy 
Accuracy of the proposed method was ascertained on the basis of recovery studies performed by standard addition 
method. To the preanalysed sample solution (40.0 µg/mL of ATN & 10.0 µg/mL of CTN) a known amount of standard 
solutions of pure drugs (ATN & CTN) were added in different levels i.e. 80%, 10.00 %, 120%. The results of recovery 
studies are shown in Table 6. 
2. Precision 
2.1 Intra-Day Precision 
It was determined by analyzing the 3 different solutions having concentration (40.0 µg/mL of ATN & 10.0 µg/mL 
of CTN) at 3 different times over a period of day. The absorbances of the resultant solution were measured at 251.0 nm and 
240.0 nm. Then these measured absorbances put in equation (1) & (2) for (ARM) The results are shown in Table 7. 
2.2 Inter-Day Precision  
It was determined by analyzing the 3 different solutions having concentration (40.0 µg/mL of ATN & 10.0 µg/mL 
of CTN) at 3 days over a period of week. The absorbances of the resultant solutions were measured at 251.0 nm and 240.0 
nm. Then these measured absorbances put in equation (1) & (2) for (ARM). The results are shown in Table 7. 
3. Repeatability 
Repeatability was determined by analyzing solution having concentration (40.0 µg/mL of ATN & 10.0 µg/mL of 
CTN) respectively for 5 times, by measuring the absorbances of these solutions at 251.0 nm and 240.0 nm. Then these 
measured absorbances put in equation (1) & (2) for (ARM). The results are shown in Table 8. 
4. Ruggedness 
Ruggedness of the proposed method is determined by analysis of aliquots from homogenous slot by two analyst 
using same operational and environmental conditions, the results are shown in Table 9. 
5. Specificity 
Accurately weighed quantity of tablet powder equivalent to (50 mg of ATN & 12.5 mg of CTN) was transferred to four 
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separate 50.0 mL of volumetric flask and was stored for 24 h under the following different conditions.  
 At 50⁰after addition of 2.0 mL of 0.1 N NaOH.  
 At 50⁰after addition of 2.0 mL of 0.1 N HCL.  
 At 50⁰after addition of 2.0 mL of 3% H2O2.  
 At room temperature (normal).  
The samples were diluted with methanol and then volume was made up to the mark and filtered through whatman 
filters (No. 41). Aliquot of the filtrate was diluted with methanol so as to get concentration equivalent to 40.0 µg/mL of ATN 
and 10.0 µg/mL of CTN. The absorbances of the resultant solutions were measured at 251.0 nm and 240.0 nm. Then these 
measured absorbances put in equation (1) & (2) for (ARM). The results are shown in Table 10. 
 
3. Results and Discussion 
Study of Overlain Spectra and Determination of   max of ATN & CTN 
 
Figure 3 Overlain Spectra of ATN and CTN 
The overlain spectrum was recorded by taking methanol as a blank. The overlain spectrum showed that the ATN & 
CTN shows their maximum absorbance at 227.0 & 251.0 nm. While the 240.0 nm was the point of equal absorbance i.e. 
Isobestic point. 
Linearity Study 
 ATN 
 
 
Figure 4 Calibration Curve of ATN at 227.0 nm (  max) 
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Table 1 Linearity Study of ATN at 227.0 nm (  max) 
Sr. No Concentration (µg/mL) Absorbance at 227.0 nm 
1 40 0.201 
2 50 0.266 
3 60 0.332 
4 70 0.392 
5 80 0.452 
Linear regression data from the calibration curve indicates good linear relationship between concentration and 
absorbance at the concentration range of (40-80 µg/mL for ATN) respectively. The linear equation for the calibration curve 
was y = 0.0006x-0.048. The r2 value was 0.999 which nearly equals to unity. 
 CTN 
 
 
Figure 5 Calibration Curve of CTN at 251.0 nm (ƛ  max) 
 
Table 2 Linearity Study of CTN at 251.0 nm (ƛ  max) 
Sr. No Concentration (µg/mL) Absorbance at 251.0 nm 
1 10 0.117 
2 12.5 0.218 
3 15 0.321 
4 17.5 0.426 
5 20 0.527 
 
Linear regression data from the calibration curve indicates good linear relationship between concentration and 
absorbance at the concentration range of (10-20 µg/mL for CTN) respectively. The linear equation for the calibration curve 
was y = 0.041x-0.295. The r2 value was 0.999 which nearly equals to unity. 
Determinations of E (1% 1cm) Values at Selected Wavelengths 
The absorbances of the solutions having concentration of 40.0 µg/mL of ATN & 10.0 µg/mL of CTN were recorded at 
wavelength 227.0 nm, 240.0 nm and 251.0 nm and E (1%, 1cm) values of drugs were calculated and results were shown in 
Table 3. The SD value in all the determinations was NMT 2 indicating fineness of the results obtained. 
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Table 3 E (1% 1cm) Values of ATN & CTN at 227.0, 251.0, 240.0 nm. 
Sr. No E (1% 1cm) at 227.0 nm E (1% 1cm) at 251.0 nm E (1% 1cm) at 240.0 nm 
 
ATN CTN ATN CTN ATN CTN 
1 595 3250 760 2590 552.5 3090 
2 596.1 3255 762 2592 552.7 3093 
3 595.3 3253 763 2594 553 3092 
4 595.7 3251 762 2591 552.1 3090 
5 595.4 3253 760 2590 552.5 3091 
Mean 595.5 3252.4 761.4 2591.4 552.56 3091.2 
SD 0.41 1.94 1.34 1.67 0.32 1.30 
 
Analysis of Standard Laboratory Mixtures 
Six laboratory mixtures were analyzed having concentration of (40.0 µg/mL of ATN & 10 µg/mL of CTN) 
respectively. And their absorbances were measured at 227.0, 251.0 nm for (SEM). 
Table 4 Results of Analysis of Standard Laboratory Mixtures by (ARM) 
Analysis of Standard Laboratory Mixtures By (ARM) 
Sr. 
No 
Amount Taken 
[µg/mL] 
Amount Found [µg/mL] % Amount Found 
 
ATN CTN ATN CTN ATN CTN 
1 40 10 39.7 9.7 99.25 97 
2 40 10 40.2 10.2 100.5 102 
3 40 10 39.5 9.8 98.75 98 
4 40 10 40.2 10.2 100.5 102 
5 40 10 39.8 10.3 99.5 103 
6 40 10 40.2 9.7 100.5 97 
 
Mean 39.93 9.98 99.83 99.83 
SD 0.307 0.278 0.769 2.78 
%RSD 0.770 2.79 0.770 2.79 
 
Analysis of Marketed Formulation Six sample solutions of marketed formulation were analyzed having concentration of 
(40.0 µg/mL of ATN & 10.0 µg/mL of CTN) respectively. And their absorbances were measured at 227.0, 251.0 nm for 
(SEM). 
Table 5 Results of Marketed Formulation Analysis by (ARM) 
Analysis of Marketed Formulation By (ARM) 
Sr. 
No 
Amount Taken 
[µg/mL] 
Amount Found 
[µg/mL] 
% Amount Found 
 
ATN CTN ATN CTN ATN CTN 
1 40 10 39.7 10.2 99.25 102 
2 40 10 39.8 10.2 99.5 102 
3 40 10 39.7 9.8 99.25 98 
4 40 10 40.5 9.8 101.25 98 
5 40 10 39.8 9.8 99.5 98 
6 40 10 39.7 9.85 99.25 98.5 
 
Mean 39.86 9.91 99.66 99.41 
SD 0.31 0.22 0.78 2.01 
%RSD 0.787 2.24 0.787 2.02 
The proposed methods when applied to marketed formulation the % drug estimated for ARM was 99.66 & 99.41 
(ATN & CTN) while % RSD was NMT more than 2 for both the methods. Indicating specific nature of developed methods 
free from the interference from the excipients in these tablets. It also showed that the developed method was successfully 
applied to analysis of marketed formulation. 
Method Validation2 
1. Accuracy this is performed on the basis of recovery studies by standard addition method. Standard solutions of pure 
drugs (ATN & CTN) were added in different levels i.e. 80%, 100 %, 120%. 
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Table 6 Results of Recovery Studies by (ARM) 
Recovery Studies by (ARM) 
Sr. 
No 
Pre-analysed Sample 
Solution [µg/mL] 
Excess Pure Drug 
Added [µg/mL] 
Recovery [µg/mL] % Recovery 
 
ATN CTN ATN CTN ATN CTN ATN CTN 
1 40 10 32 8 32 8 100 100 
2 40 10 40 10 39.9 9.9 99.75 99 
3 40 10 48 12 47.8 12.2 99.58 101.6 
 
Mean (n=3) 99.77 100.22 
SD (n=3) 0.209 1.34 
%RSD 
(n=3) 
0.21 1.34 
The mean % recovery found was 99.77 & 100.22 (ATN & CTN) by ARM while % RSD was NMT more than 2 
for both the methods indicating that the developed methods were found to be sufficiently accurate. 
 
2. Precision  
Table 7 Results of Precision Studies Intra & Inter Day by (ARM) 
Precision Studies Intra & Inter Day By (ARM) 
 
Intra-Day [n=3] Inter-Day [n=3] 
Drugs 
Amount Taken 
[µg/mL] 
Amount Found 
[µg/mL] 
%RSD 
Amount Found 
[µg/mL] 
% 
RSD 
ATN 
40 40.2 
0.52 
39.6 
0.5 40 41 39.8 
40 39.8 40 
CTN 
10 10.2 
1.73 
9.7 
1.83 10 9.8 10.1 
10 10.1 10.2 
The precision is always expressed as the % RSD around mean value. Here by both the methods %RSD for Intra-
Day and Inter-Day precision for the estimation (ATN & CTN) is NMT 2%. Hence the developed methods were found 
to be sufficiently precise. 
 
3. Repeatability 
Table 8 Results of Repeatability Studies by (ARM) 
Repeatability Studies By (ARM) 
Drug 
Amount Taken 
[µg/mL] 
Mean Amount Found 
[µg/mL] (n=5) 
%Amount Found 
(n=5) 
%RSD 
ATN 40 39.8 99.5 0.284 
CTN 10 9.91 99.1 0.285 
 
4. Ruggedness   
Table 9 Results of Ruggedness Studies by (ARM) 
Ruggedness (ARM) 
Sr. No Amount Taken [µg/mL] Analyst 
Amount Found 
[µg/mL] 
%Amount Found 
 
ATN CTN 
 
ATN CTN ATN CTN 
1 40 10 Analyst I 39.85 9.93 99.625 99.3 
2 40 10 Analyst II 40.1 9.87 100.25 98.7 
 
Mean 39.97 9.9 99.93 99 
SD 0.176 0.04 0.441 0.424 
%RSD 0.442 0.43 0.442 0.428 
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5. Specificity 
Table 10 Results of Specificity Studies by (ARM) 
Specificity (ARM) 
Sr. 
No 
Amount Taken 
[µg/mL] 
Condition 
Amount Found 
[µg/mL] 
% Amount 
Found 
 
 
ATN CTN Medium Temperature ATN CTN ATN CTN 
1 40 10 0.1 N HCL 500c 37.5 9.4 93.75 94 
2 40 10 0.1 N NaOH 500c 38.3 9.5 95.75 95 
3 40 10 3% H2O2 50
0c 35 9.6 87.5 96 
4 40 10 Normal R.T 39.2 9.8 98 98 
 
Mean 37.5 9.575 93.75 95.75 
SD 1.80 0.17 4.51 1.70 
%RSD 4.81 1.78 4.81 1.78 
 
Specificity studies are performed by exposing the tablet powder samples to different stress conditions (Acid, Base, 
Oxidative, Room temperature). The % Amount found for SEM was 93.75 & 95.75 (ATN & CTN). Such deviations from 
the results given Table 5 indicate method is capable of estimating intact drug contents free of interference from degradation 
product. 
 
4. Conclusion 
The developed UV-VIS spectrophotometric method was found to be simple, accurate, sensitive, precise, specific, 
economical and rapid. The method is very simple and involving no complicated sample preparations. The developed UV-
VIS spectrophotometric method provides suitable quantification of ATN and CTN without any positive and negative 
interference from the excipients indicating its highly specific nature. The developed UV-VIS spectrophotometric methods 
are found to be linear over wider concentration range. Therefore the developed UV-VIS spectrophotometric methods can be 
applied for routine quantitative and qualitative analysis of ATN & CTN in bulk and pharmaceutical dosage form like tablets. 
The developed UV-VIS spectrophotometric methods were validated as per the ICH guidelines. 
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